Skip to main content
AbCellera Biologics Inc. (ABCL)
NASDAQ: ABCL · Real-Time Price · USD
3.030
-0.110 (-3.50%)
At close: Feb 21, 2025, 4:00 PM
3.070
+0.040 (1.32%)
After-hours: Feb 21, 2025, 7:56 PM EST

AbCellera Biologics Revenue by Segment
Period Ending Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020
Licensing
953.00 921.00 777.00 969.00 948.00 916.00 837.00 696.00
Licensing Growth
0.53% 0.55% -7.17% 39.22% 58.53% 44.48% 11.60% 29.13%
Milestone Payments
- 251.00 - 251.00 - - 901.00 900.00
Milestone Payments Growth
- - - -72.11% - - - -
Research Fees
28.00 28.00 32.00 33.00 36.00 37.00 40.00 39.00
Research Fees Growth
-22.22% -24.32% -20.00% -15.38% 12.50% 23.33% 73.91% 129.41%
Royalty
- - - - - - - 442.00
Royalty Growth
- - - - - - - -14.34%

Operating Metrics

Period Ending Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020
Partnered Program Starts
- - - 404.00 392.00 374.00 356.00 339.00 342.00 319.00 291.00
Partnered Program Starts Growth
- - - 19.17% 14.62% 17.24% 22.34% 29.89% 45.53% 47.00% 41.95%
Programs Under Contract
- - - 203.00 182.00 177.00 177.00 174.00 164.00 164.00 158.00
Programs Under Contract Growth
- - - 16.67% 10.98% 7.93% 12.03% 11.54% 5.81% 18.84% 32.77%
Number of Molecules in the Clinic
54.00 50.00 45.00 41.00 36.00 33.00 30.00 27.00
Number of Molecules in the Clinic Growth
50.00% 51.52% 50.00% 51.85% 50.00% 50.00% 50.00% 80.00%
Number of Discovery Partners
- - - 46.00 42.00 41.00 41.00 40.00 38.00 38.00 36.00
Number of Discovery Partners Growth
- - - 15.00% 10.53% 7.89% 13.89% 11.11% 8.57% 15.15% 24.14%
Source: Business metrics provided by Main Street Data and sourced from official company press releases and documents.